Survivor Stories
A new targeted therapeutic has been "a reset on my life,” says Alexandra Vitale, 31, who was diagnosed with von Hippel-Lindau (VHL) disease at the age of 5. VHL causes both benign and malignant tumors.
Read Alexandra's Story
A new targeted therapeutic has been "a reset on my life,” says Alexandra Vitale, 31, who was diagnosed with von Hippel-Lindau (VHL) disease at the age of 5. VHL causes both benign and malignant tumors.
Read Alexandra's Story
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThe AACR has a long history of advancing cancer health equity through programs and initiatives including the trailblazing Cancer Health Disparities conference and the first-of-its-kind Cancer Disparities Progress Report.
Learn MoreMore than 64,000 people in the United States were diagnosed with pancreatic cancer this year. Learn about the treatment options for this type of cancer.
Learn MoreAACR Project GENIE is a publicly accessible international cancer registry of real-world data assembled through data sharing between many of the leading cancer centers in the world.
Learn MoreThe Week in Cancer News: A roundup of significant cancer research news from the past week, selected by the staff of Cancer Today magazine.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research (AACR) has a lasting impact.
Donate NowSession recordings are available to registered attendees through July 19. Access to the sessions is still available for purchase.
The AACR Cancer Progress Report 2022 provides a comprehensive overview of the latest research-driven advances against the collection of devastating diseases called cancer.
Learn MoreThe AACR and its more than 54,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreAACR President Lisa M. Coussens, PhD, FAACR, discusses the research-driven advances against cancer and looks to the future of cancer science and medicine.
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Moretherapeutics against cancer were approved by the FDA from August 1, 2021, to July 31, 2022
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2019
Learn MoreYour donation to the American Association for Cancer Research helps our more than 54,000 members worldwide drive progress against cancer.
Donate Now
